Emily E Anderson1, Silvia Tejeda2, Kimberly Childers2, Melinda R Stolley2, Richard B Warnecke2, Kent F Hoskins2. 1. Neiswanger Institute for Bioethics, Loyola University Chicago Stritch School of Medicine, Maywood; College of Medicine, University of Illinois at Chicago; Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL; Medical College of Wisconsin, Milwaukee, WI; and Disney Family Center at Providence St Joseph Medical Center, Burbank, CA emanderson@luc.edu. 2. Neiswanger Institute for Bioethics, Loyola University Chicago Stritch School of Medicine, Maywood; College of Medicine, University of Illinois at Chicago; Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL; Medical College of Wisconsin, Milwaukee, WI; and Disney Family Center at Providence St Joseph Medical Center, Burbank, CA.
Abstract
PURPOSE: The US Preventive Services Task Force recommends identifying candidates for breast cancer (BC) chemoprevention and referring them for genetic counseling as part of routine care. Little is known about the feasibility of implementing these recommendations or how low-income women of color might respond to individualized risk assessment (IRA) performed by primary care providers (PCPs). METHODS: Women recruited from a federally qualified health center were given the option to discuss BC risk status with their PCP. Comprehensive IRA was performed using a software tool designed for the primary care environment combining three assessment instruments and providing risk-adapted recommendations for screening, prevention, and genetic referral. Logistic regression models assessed factors associated with wanting to learn and discuss BC risk with PCP. RESULTS: Of 237 participants, only 12.7% (n = 30) did not want to discuss IRA results with their PCP. Factors associated with lower odds of wanting to learn results included having private insurance and reporting ever having had a mammogram. Factors associated with higher odds of wanting to learn results included older age (50 to 69 years) and increased BC worry. For all women wishing to learn results, IRA was successfully completed and delivered to the PCP immediately before the encounter for incorporation into the well-visit evaluation. CONCLUSION: Incorporation of US Preventive Services Task Force recommendations as part of routine primary care is feasible. Interest in IRA seems high among underserved women. This approach warrants further investigation as a strategy for addressing disparities in BC mortality.
PURPOSE: The US Preventive Services Task Force recommends identifying candidates for breast cancer (BC) chemoprevention and referring them for genetic counseling as part of routine care. Little is known about the feasibility of implementing these recommendations or how low-income women of color might respond to individualized risk assessment (IRA) performed by primary care providers (PCPs). METHODS:Women recruited from a federally qualified health center were given the option to discuss BC risk status with their PCP. Comprehensive IRA was performed using a software tool designed for the primary care environment combining three assessment instruments and providing risk-adapted recommendations for screening, prevention, and genetic referral. Logistic regression models assessed factors associated with wanting to learn and discuss BC risk with PCP. RESULTS: Of 237 participants, only 12.7% (n = 30) did not want to discuss IRA results with their PCP. Factors associated with lower odds of wanting to learn results included having private insurance and reporting ever having had a mammogram. Factors associated with higher odds of wanting to learn results included older age (50 to 69 years) and increased BC worry. For all women wishing to learn results, IRA was successfully completed and delivered to the PCP immediately before the encounter for incorporation into the well-visit evaluation. CONCLUSION: Incorporation of US Preventive Services Task Force recommendations as part of routine primary care is feasible. Interest in IRA seems high among underserved women. This approach warrants further investigation as a strategy for addressing disparities in BC mortality.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Erika A Waters; Timothy S McNeel; Worta McCaskill Stevens; Andrew N Freedman Journal: Breast Cancer Res Treat Date: 2012-05-24 Impact factor: 4.872
Authors: Vida Henderson; Shaila M Strayhorn; Nyahne Q Bergeron; Desmona C Strahan; Pamela S Ganschow; Aditya S Khanna; Karriem Watson; Kent Hoskins; Yamile Molina Journal: Cancer Control Date: 2022 Jan-Dec Impact factor: 2.339
Authors: Victoria G Woof; Helen Ruane; David P French; Fiona Ulph; Nadeem Qureshi; Nasaim Khan; D Gareth Evans; Louise S Donnelly Journal: BMC Cancer Date: 2020-05-20 Impact factor: 4.430